CN Patent

CN104341343B — 贝曲西班的晶型及其制备方法和用途

Assigned to Sichuan Haisco Pharmaceutical Co Ltd · Expires 2018-09-28 · 8y expired

What this patent protects

本发明公开了一种Xa因子抑制剂贝曲西班的晶型及其制备方法，以及含有这些贝曲西班晶型的药物组合物和这些贝曲西班晶型在制备用于预防或治疗哺乳动物以不良血栓形成为特征的病症的药物的用途。

USPTO Abstract

本发明公开了一种Xa因子抑制剂贝曲西班的晶型及其制备方法，以及含有这些贝曲西班晶型的药物组合物和这些贝曲西班晶型在制备用于预防或治疗哺乳动物以不良血栓形成为特征的病症的药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104341343B
Jurisdiction
CN
Classification
—
Expires
2018-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Haisco Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.